Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Parex Resources Announces Nomination of Six Directors to GeoPark’s Board
-
Xanadu to Host Analyst Day on March 4, 2026
-
Founder Group Limited Receives NASDAQ Notification Regarding Minimum Publicly Held Shares Deficiency
-
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Abony Acquisition Corp. I Announces Closing of $230 Million Initial Public Offering Including Exercise of Underwriter’s Over-Allotment Option in Full
-
Electra Upsizes At-The-Market Offering
-
22nd Century Group Preliminarily Reports Fourth Quarter and Full Year 2025 Financial Results
-
Orange County Bancorp, Inc. Declares Cash Dividend
-
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Ninepoint Partners Announces February 2026 Cash Distributions for its ETFs and ETF Series Securities
-
American Coastal Insurance Corporation Announces the Appointment of Troy Crawford as Chief Underwriting Officer
-
Colliers Extends Maturity and Enhances Flexibility of its US$2.25 Billion Credit Facility
-
Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public Offering
-
U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026
-
Capital Clean Energy Carriers Corp. Announces Pricing of €250 Million Unsecured Bonds
-
OTTAWA BANCORP, INC. EXTENDS STANDSTILL AGREEMENT WITH STILWELL GROUP
-
Foresight Announced ADS Ratio Change
-
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
-
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
DATA BREACH INVESTIGATION: Choice Hotels International, Inc. Franchisees and Customers Who Have Received a Notice of Data Breach Are Encouraged to Contact Edelson Lechtzin LLP
-
Amicus Therapeutics Announces Full-Year 2025 Financial Results and Corporate Updates
-
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
TAK Broadband Data Breach Claims Investigated by Lynch Carpenter
-
Ninepoint Partners Announces Estimated February 2026 Cash Distributions for Ninepoint Cash Management Fund - ETF Series
-
Update for the James Bay Niobium Project
-
WIRX Pharmacy Data Breach Claims Investigated by Lynch Carpenter
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
-
Surge Copper Announces Berg Project Acceptance into BC Critical Minerals Office
-
Century Aluminum Company Statement on U.S. Supreme Court IEEPA Ruling
-
Eupraxia Pharmaceuticals Announces Closing of US$63.2 Million Public Offering Including Full Exercise of Underwriter Option
-
Inscope Raises $14.5M Series A to Replace Manual Financial Statement Preparation for Accounting Firms and Enterprises
-
ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
-
PYPL Investors Have Opportunity to Lead PayPal Holdings, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in
-
PSFE Investors Have Opportunity to Lead Paysafe Limited Securities Fraud Lawsuit with the Schall Law Firm
-
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophreni
-
Lessing’s Hospitality Group Opens Shoreline Café at Catholic Health’s Good Samaritan University Hospital in West Islip, NY
-
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm
-
Glen Burnie Bancorp Announces Retirement of Board Chair John Demyan and Appointment of New Board Chair Jay Baldwin
-
Cleanroom Film & Bags Adds High-speed Converting Line to Serve Increasing Demand for Cleanroom Bags
-
Cleanroom Film & Bags Adds High-speed Converting Line to Serve Increasing Demand for Cleanroom Bags
-
Optica Names 22 Recipients for 2026 Awards and Medals
-
In NCLA Win, Supreme Court Agrees Trump Admin. Cannot Use IEEPA to Impose Emergency Tariffs
-
Federal Home Loan Bank of New York Announces Full-Year and Fourth Quarter 2025 Operating Highlights
-
Kaldvik AS (KLDVK): Q4 2025 Quarterly Update and Webcast - 25 February 2026
